Literature DB >> 12929737

Thyroid hormone action: insight from transgenic mouse models.

Fredric E Wondisford1.   

Abstract

Thyroid hormone receptors (TRs) are cellular homologues of the viral erythroblastic leukemia oncogene (v-erbA). TRs (c-crbA isoforms) are derived from two separate gene loci in mammals: a and beta. Through a series of knockout experiments in mice in which one or several of the TR isoforms were deleted, it has been demonstrated that the TR-beta isoforms control central regulation of thyroid-stimulating hormone. Of these isoforms, TR-beta2 is the most important in mediating negative feedback control of the hypothalamic-pituitary-thyroid axis. Further analysis of TR knockout animals revealed, however, that they exhibited a much milder overall phenotype than hypothyroid animals, indicating that receptor loss was not equivalent to ligand loss in vivo. To understand this apparent paradox, we generated animals expressing a non-T3 binding receptor (delta337T) from the TR-beta allele. These mice displayed a complete hypothyroid phenotype, demonstrating that the unliganded TR mediates the effect of hypothyroidism. Because this mutant TR constitutively binds to nuclear coreprssors, it also suggests that this class of proteins is essential for mediating hypothyroidism in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12929737     DOI: 10.1136/jim-51-04-22

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  20 in total

1.  Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.

Authors:  Michael L Goodson; Brenda J Mengeling; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

2.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

3.  The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors.

Authors:  Martin L Privalsky; Sangho Lee; Johnnie B Hahm; Briana M Young; Rebecca N G Fong; Ivan H Chan
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

4.  Fundamentally distinct roles of thyroid hormone receptor isoforms in a thyrotroph cell line are due to differential DNA binding.

Authors:  Maria I Chiamolera; Aniket R Sidhaye; Shunichi Matsumoto; Qiyi He; Koshi Hashimoto; Tania M Ortiga-Carvalho; Fredric E Wondisford
Journal:  Mol Endocrinol       Date:  2012-05-08

5.  A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)beta2.

Authors:  Sangho Lee; Briana M Young; Wei Wan; Ivan H Chan; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2011-05-26

6.  Research resource: identification of novel coregulators specific for thyroid hormone receptor-β2.

Authors:  Johnnie B Hahm; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2013-04-04

Review 7.  Deiodinases: implications of the local control of thyroid hormone action.

Authors:  Antonio C Bianco; Brian W Kim
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

8.  The thyroid hormone receptors as modulators of skin proliferation and inflammation.

Authors:  Constanza Contreras-Jurado; Laura García-Serrano; Mariana Gómez-Ferrería; Clotilde Costa; Jesús M Paramio; Ana Aranda
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

9.  Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1.

Authors:  Ivan H Chan; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2009-07-23

10.  Molecular components underlying nongenomic thyroid hormone signaling in embryonic zebrafish neurons.

Authors:  Marc A Yonkers; Angeles B Ribera
Journal:  Neural Dev       Date:  2009-06-08       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.